The global CHO Cell Line Construction Service market was valued at US$ 1097 million in 2023 and is anticipated to reach US$ 2286 million by 2030, witnessing a CAGR of 11.2% during the forecast period 2024-2030.
Chinese hamster ovary (CHO) cells are the primary mammalian cell lines utilized to produce monoclonal antibodies (mAbs). Cell Line Construction is the engineering of a cell line, often mammalian, to produce a therapeutic biomolecule or biologic. It allows scientists to tailor cultures depending on the applications and desired properties of the targeted product. Creating a robust, stable cell line that can yield sufficient material for testing, optimization, and manufacturing at commercial scales is a crucial step in bioprocess development.
North American market for CHO Cell Line Construction Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for CHO Cell Line Construction Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for CHO Cell Line Construction Service in Pharmaceuticals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of CHO Cell Line Construction Service include Lonza, Thermo Fisher Scientific, Sartorius, Boehringer Ingelheim BioXcellence, WuXi Biologics, Merck, Catalent, Samsung Biologics, FUJIFILM Diosynth Biotechnologies, Beckman Coulter, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for CHO Cell Line Construction Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CHO Cell Line Construction Service.
The CHO Cell Line Construction Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global CHO Cell Line Construction Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CHO Cell Line Construction Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Lonza
Thermo Fisher Scientific
Sartorius
Boehringer Ingelheim BioXcellence
WuXi Biologics
Merck
Catalent
Samsung Biologics
FUJIFILM Diosynth Biotechnologies
Beckman Coulter
Rentschler Biopharma
ProBioGen
AGC Biologics
Guangzhou Cantonbio
Charles River Laboratories
Mycenax Biotech
Shanghai Ruizhi Chemical Research
Shanghai OPM Biosciences
Beijing Joinn Biologics
Chime Biologics
Great Bay Bio
Segment by Type
Knockout CHO Cell Lines
Overexpression CHO Cell Lines
Inducible Expression CHO Cell Lines
Others
Segment by Application
Pharmaceuticals
Bioengineering
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CHO Cell Line Construction Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CHO Cell Line Construction Service Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Knockout CHO Cell Lines
1.2.3 Overexpression CHO Cell Lines
1.2.4 Inducible Expression CHO Cell Lines
1.2.5 Others
1.3 Market by Application
1.3.1 Global CHO Cell Line Construction Service Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceuticals
1.3.3 Bioengineering
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global CHO Cell Line Construction Service Market Perspective (2019-2030)
2.2 Global CHO Cell Line Construction Service Growth Trends by Region
2.2.1 Global CHO Cell Line Construction Service Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 CHO Cell Line Construction Service Historic Market Size by Region (2019-2024)
2.2.3 CHO Cell Line Construction Service Forecasted Market Size by Region (2025-2030)
2.3 CHO Cell Line Construction Service Market Dynamics
2.3.1 CHO Cell Line Construction Service Industry Trends
2.3.2 CHO Cell Line Construction Service Market Drivers
2.3.3 CHO Cell Line Construction Service Market Challenges
2.3.4 CHO Cell Line Construction Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CHO Cell Line Construction Service Players by Revenue
3.1.1 Global Top CHO Cell Line Construction Service Players by Revenue (2019-2024)
3.1.2 Global CHO Cell Line Construction Service Revenue Market Share by Players (2019-2024)
3.2 Global CHO Cell Line Construction Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by CHO Cell Line Construction Service Revenue
3.4 Global CHO Cell Line Construction Service Market Concentration Ratio
3.4.1 Global CHO Cell Line Construction Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CHO Cell Line Construction Service Revenue in 2023
3.5 Global Key Players of CHO Cell Line Construction Service Head office and Area Served
3.6 Global Key Players of CHO Cell Line Construction Service, Product and Application
3.7 Global Key Players of CHO Cell Line Construction Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 CHO Cell Line Construction Service Breakdown Data by Type
4.1 Global CHO Cell Line Construction Service Historic Market Size by Type (2019-2024)
4.2 Global CHO Cell Line Construction Service Forecasted Market Size by Type (2025-2030)
5 CHO Cell Line Construction Service Breakdown Data by Application
5.1 Global CHO Cell Line Construction Service Historic Market Size by Application (2019-2024)
5.2 Global CHO Cell Line Construction Service Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America CHO Cell Line Construction Service Market Size (2019-2030)
6.2 North America CHO Cell Line Construction Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America CHO Cell Line Construction Service Market Size by Country (2019-2024)
6.4 North America CHO Cell Line Construction Service Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe CHO Cell Line Construction Service Market Size (2019-2030)
7.2 Europe CHO Cell Line Construction Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe CHO Cell Line Construction Service Market Size by Country (2019-2024)
7.4 Europe CHO Cell Line Construction Service Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific CHO Cell Line Construction Service Market Size (2019-2030)
8.2 Asia-Pacific CHO Cell Line Construction Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific CHO Cell Line Construction Service Market Size by Region (2019-2024)
8.4 Asia-Pacific CHO Cell Line Construction Service Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America CHO Cell Line Construction Service Market Size (2019-2030)
9.2 Latin America CHO Cell Line Construction Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America CHO Cell Line Construction Service Market Size by Country (2019-2024)
9.4 Latin America CHO Cell Line Construction Service Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CHO Cell Line Construction Service Market Size (2019-2030)
10.2 Middle East & Africa CHO Cell Line Construction Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa CHO Cell Line Construction Service Market Size by Country (2019-2024)
10.4 Middle East & Africa CHO Cell Line Construction Service Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Lonza
11.1.1 Lonza Company Details
11.1.2 Lonza Business Overview
11.1.3 Lonza CHO Cell Line Construction Service Introduction
11.1.4 Lonza Revenue in CHO Cell Line Construction Service Business (2019-2024)
11.1.5 Lonza Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific CHO Cell Line Construction Service Introduction
11.2.4 Thermo Fisher Scientific Revenue in CHO Cell Line Construction Service Business (2019-2024)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Sartorius
11.3.1 Sartorius Company Details
11.3.2 Sartorius Business Overview
11.3.3 Sartorius CHO Cell Line Construction Service Introduction
11.3.4 Sartorius Revenue in CHO Cell Line Construction Service Business (2019-2024)
11.3.5 Sartorius Recent Development
11.4 Boehringer Ingelheim BioXcellence
11.4.1 Boehringer Ingelheim BioXcellence Company Details
11.4.2 Boehringer Ingelheim BioXcellence Business Overview
11.4.3 Boehringer Ingelheim BioXcellence CHO Cell Line Construction Service Introduction
11.4.4 Boehringer Ingelheim BioXcellence Revenue in CHO Cell Line Construction Service Business (2019-2024)
11.4.5 Boehringer Ingelheim BioXcellence Recent Development
11.5 WuXi Biologics
11.5.1 WuXi Biologics Company Details
11.5.2 WuXi Biologics Business Overview
11.5.3 WuXi Biologics CHO Cell Line Construction Service Introduction
11.5.4 WuXi Biologics Revenue in CHO Cell Line Construction Service Business (2019-2024)
11.5.5 WuXi Biologics Recent Development
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Merck Business Overview
11.6.3 Merck CHO Cell Line Construction Service Introduction
11.6.4 Merck Revenue in CHO Cell Line Construction Service Business (2019-2024)
11.6.5 Merck Recent Development
11.7 Catalent
11.7.1 Catalent Company Details
11.7.2 Catalent Business Overview
11.7.3 Catalent CHO Cell Line Construction Service Introduction
11.7.4 Catalent Revenue in CHO Cell Line Construction Service Business (2019-2024)
11.7.5 Catalent Recent Development
11.8 Samsung Biologics
11.8.1 Samsung Biologics Company Details
11.8.2 Samsung Biologics Business Overview
11.8.3 Samsung Biologics CHO Cell Line Construction Service Introduction
11.8.4 Samsung Biologics Revenue in CHO Cell Line Construction Service Business (2019-2024)
11.8.5 Samsung Biologics Recent Development
11.9 FUJIFILM Diosynth Biotechnologies
11.9.1 FUJIFILM Diosynth Biotechnologies Company Details
11.9.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.9.3 FUJIFILM Diosynth Biotechnologies CHO Cell Line Construction Service Introduction
11.9.4 FUJIFILM Diosynth Biotechnologies Revenue in CHO Cell Line Construction Service Business (2019-2024)
11.9.5 FUJIFILM Diosynth Biotechnologies Recent Development
11.10 Beckman Coulter
11.10.1 Beckman Coulter Company Details
11.10.2 Beckman Coulter Business Overview
11.10.3 Beckman Coulter CHO Cell Line Construction Service Introduction
11.10.4 Beckman Coulter Revenue in CHO Cell Line Construction Service Business (2019-2024)
11.10.5 Beckman Coulter Recent Development
11.11 Rentschler Biopharma
11.11.1 Rentschler Biopharma Company Details
11.11.2 Rentschler Biopharma Business Overview
11.11.3 Rentschler Biopharma CHO Cell Line Construction Service Introduction
11.11.4 Rentschler Biopharma Revenue in CHO Cell Line Construction Service Business (2019-2024)
11.11.5 Rentschler Biopharma Recent Development
11.12 ProBioGen
11.12.1 ProBioGen Company Details
11.12.2 ProBioGen Business Overview
11.12.3 ProBioGen CHO Cell Line Construction Service Introduction
11.12.4 ProBioGen Revenue in CHO Cell Line Construction Service Business (2019-2024)
11.12.5 ProBioGen Recent Development
11.13 AGC Biologics
11.13.1 AGC Biologics Company Details
11.13.2 AGC Biologics Business Overview
11.13.3 AGC Biologics CHO Cell Line Construction Service Introduction
11.13.4 AGC Biologics Revenue in CHO Cell Line Construction Service Business (2019-2024)
11.13.5 AGC Biologics Recent Development
11.14 Guangzhou Cantonbio
11.14.1 Guangzhou Cantonbio Company Details
11.14.2 Guangzhou Cantonbio Business Overview
11.14.3 Guangzhou Cantonbio CHO Cell Line Construction Service Introduction
11.14.4 Guangzhou Cantonbio Revenue in CHO Cell Line Construction Service Business (2019-2024)
11.14.5 Guangzhou Cantonbio Recent Development
11.15 Charles River Laboratories
11.15.1 Charles River Laboratories Company Details
11.15.2 Charles River Laboratories Business Overview
11.15.3 Charles River Laboratories CHO Cell Line Construction Service Introduction
11.15.4 Charles River Laboratories Revenue in CHO Cell Line Construction Service Business (2019-2024)
11.15.5 Charles River Laboratories Recent Development
11.16 Mycenax Biotech
11.16.1 Mycenax Biotech Company Details
11.16.2 Mycenax Biotech Business Overview
11.16.3 Mycenax Biotech CHO Cell Line Construction Service Introduction
11.16.4 Mycenax Biotech Revenue in CHO Cell Line Construction Service Business (2019-2024)
11.16.5 Mycenax Biotech Recent Development
11.17 Shanghai Ruizhi Chemical Research
11.17.1 Shanghai Ruizhi Chemical Research Company Details
11.17.2 Shanghai Ruizhi Chemical Research Business Overview
11.17.3 Shanghai Ruizhi Chemical Research CHO Cell Line Construction Service Introduction
11.17.4 Shanghai Ruizhi Chemical Research Revenue in CHO Cell Line Construction Service Business (2019-2024)
11.17.5 Shanghai Ruizhi Chemical Research Recent Development
11.18 Shanghai OPM Biosciences
11.18.1 Shanghai OPM Biosciences Company Details
11.18.2 Shanghai OPM Biosciences Business Overview
11.18.3 Shanghai OPM Biosciences CHO Cell Line Construction Service Introduction
11.18.4 Shanghai OPM Biosciences Revenue in CHO Cell Line Construction Service Business (2019-2024)
11.18.5 Shanghai OPM Biosciences Recent Development
11.19 Beijing Joinn Biologics
11.19.1 Beijing Joinn Biologics Company Details
11.19.2 Beijing Joinn Biologics Business Overview
11.19.3 Beijing Joinn Biologics CHO Cell Line Construction Service Introduction
11.19.4 Beijing Joinn Biologics Revenue in CHO Cell Line Construction Service Business (2019-2024)
11.19.5 Beijing Joinn Biologics Recent Development
11.20 Chime Biologics
11.20.1 Chime Biologics Company Details
11.20.2 Chime Biologics Business Overview
11.20.3 Chime Biologics CHO Cell Line Construction Service Introduction
11.20.4 Chime Biologics Revenue in CHO Cell Line Construction Service Business (2019-2024)
11.20.5 Chime Biologics Recent Development
11.21 Great Bay Bio
11.21.1 Great Bay Bio Company Details
11.21.2 Great Bay Bio Business Overview
11.21.3 Great Bay Bio CHO Cell Line Construction Service Introduction
11.21.4 Great Bay Bio Revenue in CHO Cell Line Construction Service Business (2019-2024)
11.21.5 Great Bay Bio Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
Lonza
Thermo Fisher Scientific
Sartorius
Boehringer Ingelheim BioXcellence
WuXi Biologics
Merck
Catalent
Samsung Biologics
FUJIFILM Diosynth Biotechnologies
Beckman Coulter
Rentschler Biopharma
ProBioGen
AGC Biologics
Guangzhou Cantonbio
Charles River Laboratories
Mycenax Biotech
Shanghai Ruizhi Chemical Research
Shanghai OPM Biosciences
Beijing Joinn Biologics
Chime Biologics
Great Bay Bio
听
听
*If Applicable.
